About
Basic Data Updated:
2 months agoThe Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.75 cr and a paid-up capital of Rs 1.30 cr.
The Corporate currently has active open charges totaling ₹15.22 cr.
Manvendra Singh and Nimish Gupta serve as directors at the Company.
Industry
Company Details
- Location
North Delhi, Delhi, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24239DL2001PTC110738 |
| Company No. | 110738 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 08 May 2001 |
| Date of AGM | 30 Nov 2021 |
| Date of Balance Sheet | 31 Mar 2021 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Financials of Sgs Pharmaceutical Pvt Ltd
Sgs Pharmaceutical Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 20.29% increase. The company also saw a substantial improvement in profitability, with a 30.69% increase in profit. The company's net worth Soared by an impressive increase of 15.67%.
Corporate Structure
Unlock access to Sgs Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sgs Pharmaceutical Pvt Ltd
Unlock and access historical data on people associated with Sgs Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Oct 2020 | ₹3.50 M | Open |
State Bank Of India Creation Date: 04 Jan 2006 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 04 Jan 2006 | ₹10.51 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sgs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgs Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Charges
A charge with State Bank Of India of Rs. 10.51 cr registered on 04 Jan 2006 with Charge ID 80061610 was modified on 10 Jul 2023.
10 Jul 2023Annual General Meeting
Sgs Pharmaceutical Pvt Ltd last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
30 Nov 2021Balance Sheet
Sgs Pharmaceutical Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi.
31 Mar 2021Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.35 cr with Charge ID 100418251 was registered on 29 Oct 2020.
29 Oct 2020Director Appointment
Manvendra Singh was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 5 years 7 months .
30 Jan 2019
Recent News, Updates & Announcement
SGS Revolutionizes PBMC Collection and Usage for Infectious Disease and Vaccine Research with New Techniques and Processes.SGS now has better techniques for collecting and using PBMCs in early clinical trials making them a top choice for infectious disease and vaccine research These cells are important for studying diseases and biological effects but can be tricky to handle SGS has developed new processes like allinone tubes to make it easier and more efficient.
PharmTech 06 Sep 2018
Frequently asked questions
What is the Incorporation or founding date of Sgs Pharmaceutical Pvt Ltd?
